Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Patent
1995-04-06
1998-07-14
Scheiner, Toni R.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
530327, 530328, 530329, 530330, 530331, C07K 500, C07K 700, C07K 1700
Patent
active
057805873
ABSTRACT:
Methods of treating an individual with Alzheimer's Disease by administering to the patient a therapeutically effective dose of a compound which interferes with the interaction between Alzheimer .beta.-protein and Apolipoprotein E4 or .alpha..sub.1 -antichymotrypsin, thereby suppressing the formation of Alzheimer .beta.-protein filaments and the neurotoxic effects of these filaments. The present invention also refers to methods of screening for compounds which are effective drugs for treating Alzheimer's disease. These methods comprise screening for compounds which suppress the formation of Alzheimer .beta.-protein filaments in the presence of promoting factors and which suppress the neurotoxic effects of these filaments formed in the presence of promoting factors.
REFERENCES:
patent: 4303592 (1981-12-01), Laura et al.
patent: 4666829 (1987-05-01), Glenner et al.
Kirschner et al PNAS, USA vol. 84 p. 6953, Oct. 1987.
Wong et al, Biochem. Biophys. Res. Comm. vol. 166 p. 984, Jan. 1990.
Abraham et al, Biotechnology vol. 7, p. 147, Feb. 1989.
Glenner et al Biochem. Biophys. Res. Comm. vol. 120 p. 885, May 1984.
Halverson et al Biochemiostry vol. 29 p. 2639, Mar. 1990.
Yankner et al, Science vol. 250 p. 279, Oct. 1990.
Fraser et al, J. Nerurochemistry vol. 671 p. 298, Jul. 1993.
Okado et al Biochem. Biophys. Res. Comm. vol. 189 p. 1561, Dec. 1992.
Matsumoto et al Eur. J. Biochem. vol. 225 p. 1055, Nov. 1994.
Castano et al Biochem. Biophys. Res Comm. vol. 141 p. 782, Dec. 1986.
C. W. Wong et al. "Neuritic Plaques and Cerebrovascular Amyloid in Alzheimer Disease are Antigenically Related," Proc. Natl. Acad. Sci. USA 82:8729-8732 (Dec. 1985).
Strittmatter, W. J., et al., "Binding of Human Apolipoprotein E to Synthetic Amyloid .beta. Peptide: Isoform-Specific Effects and Implications for Late-Onset Alzheimer Disease," Proc. Natl. Acad. Sci. USA, 90:8098-8102 (Sep. 1993).
Smith, C., and Anderton, B. H."The Molecular Pathology of Alzheimer's Disease: are we any closer to understanding the neurodegenerative process?," Neuropathology and Applied Neurobiology, 20:322-338 (1994).
Singh, V. K., "Studies of Neuroimmune Markers in Alzheimer's Disease," Molecular Neurobiology, 9(1-3):73-81 (1994).
Cacabelos, R., et al., "Cerebrospinal Fluid Interleukin-1.beta. (IL-1.beta.) in Alzheimer's Disease and Neurological Disorders," Meth. Find. Exp. Clin. Pharmacol., 13(7):455-458 (1991).
Fraser, P. E., et al., ".alpha..sub.1 -Antichymotrypsin Binding to Alzheimer A.beta. Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro," J. of Nurochem., 61(1):298-305 (1993).
Nelson, R. B. and Siman, R., "Clipsin, a Chymotrypsin-Like Protease in Rat Brain Which is Irreversibly Inhibited by .alpha.-1-Antichymotrysin," J. of Biol. Chem., 265(7):3836-3842 (1990).
Nelson, R. B. and Siman, R., "Clipsin, a Chymotrypsin-Like Protease in Rat Brain Which is Irreversibly Inhibited by .alpha.-1-Antichymotrypsin," J. of Biol. Chem., 266(19):12796 (1991).
Abraham, C. R., et al., "A Calcium-Activated Protease From Alzheimer's Disease Brain Cleaves at the N-Terminus of the Amyloid .beta.-Protein," Biochem. and Biophys. Research Comm., 174(2):790-796 (1991).
Neve, R. L. and Potter, H., "Molecular Biology of Alzheimer Amyloid Plaque Proteins," In Brosus, Jugel and Freman, Roberts T. (ed.), Molecular Genetic Approaches to Neuropsychiatric Disease, (Academic Press Inc., San Diego) pp. 281-305 (1991).
Potter, H., et al., "The Two Alzheimer Amyloid Components .alpha..sub.1 -Antichymotrypsin and .beta.-Protein Form a Stable Complex In Vitro" Neurobiol. of Aging, 11 (3):245 (1990).
Potter, H., et al., "The Two Alzheimer Amyloid Components .alpha..sub.1 -Antichymotrypsin and .beta.-Protein Form a Stable Complex In Vitro," In K. Iqbal, et al. (Ed.), Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies (NY: John Wiley & Sons Ltd.), pp. 275-280 ((1991).
Yanker, B. A., et al., "Neurotrophic and Neurotoxic Effects of Amyloid .beta. Protein: Reversal by Tachykinin Neuropeptides," Science, 250:279-282 (1990).
Whitson, J. S., et al., "Amyloid .beta. Protein Enhances the Survival of Hippocampal Neurons In Vitro," Science, 243:1488-1490 (1989).
Potter, H. et al., "The Involvement of Proteases, Protease Inhibitors, and an Acute Phase Response in Alzheimer's Disease," Annals NY Acad. Sci. pp. 161-173 (1992).
Kayyali, U. S. et al., "Characterization of Amyloid Precursor Protein-Associated Serine Esterase Activity in Different Cell Lines," Washington, D.C., Nov. 7-12 (1993), Abstract 669.7.
Kayyali, U. S., et al., "Identification of Adrelase-A Serine Hydrolase Intrinsic to the Alzheimer Amyloid Precursor Protein," Advances in the Biosciences, 87:221-222 (1993).
Abraham, C. R., et al., "Immunochemical Identification of the Serine Protease Inhibitor .alpha..sub.1 -Antichymotrypsin in the Brain Amyloid Deposits of Alzheimer's Disease," Cell, 52:487-501, (Feb. 26, 1988).
Dressler, D., et al., Abstracts of the Society for Neuroscience, vol. 15, Part 2, p. 1041, Abstract No. 414.20 "In Vitro Studies of the Interaction Between the Alzheimer Components .alpha..sub.1 -Antichymotrypsin and .beta.-Protein" (1989).
Abraham, C. R. et al.,".alpha..sub.1 -Antichymotrypsin Is Associated Solely with Amyloid Deposits Containing the .beta.-Protein Amyloid and Cell Localization of .alpha..sub.1 -Antichymotrypsin, " Neurobiol. Aging, 11(2):123-129 (1990).
Rozemuller, J. M., et al., "Acute Phase Proeins in Amorphous and Classical Plaques; Differences Between Vascular and Plaque Amyloid," Neurobiol. Aging, 11:310, Abstract No. 238 (1990).
Kirschner, D. A. et al., "Synthetic Peptide Homologous to .beta.-Protein from Alzheimer Disease Forms Amyloid-Like Fibrils In Vitro," Proc. Nat. Acad. Sci. USA, 84:6963-6957 (1987).
Bugiani, O., et al., "Synaptic Alterations in Preamyloid Deposits," Neurobiol. Aging, 11:310, Abstract No. 236 (1990).
Castano, E. M., et al., "In Vitro Formation of Amyloid Fibrils from Two Synthetic Peptides of Different Lengths Homologous to Alzheimer's Disease .beta.-Protein," Biochem. Biophys. Res. Commun., 141(2):782-789 (1986).
Abraham, C. R., and Potter, H. "Alzheimer's Disease: Recent Advances in Understanding the Brain Amyloid Deposits," Bio/Technology, 7:147-153 (1989).
Travis, J., et al., "Human .alpha.-1-Antichymotrypsin:Interaction with Chymotrypsin-Like Proteinases," Biochemistry, 17(26):5651-5656 (1978).
Reconstruction of poster believed to be presented by Dr. Potter at the Second International Conference on Alzheimer's Disease and Related Disorders (Toronto, Canada) Jul. 15-20, 1990 (pp. 1-6).
Reconstruction of poster believed to be presented by Dressler and Potter at the Annual Meeting of the Society for Neuroscience, Oct. 29, 1989 (3 pages).
Namba, Y., et al., "Apolipoprotein E Immunoreactivity in Cerebral Amyloid Deposits and Neurofibrillary Tangles in Alzheimer's Disease and Kuru Plaque Amyloid in Creutzfeldt-Jakob Disease," Brain Research, 541:163-166 (1991).
Wisniewski, T. and Frangione, B., "Apolipoprotein E: a Pathological Chaperone Protein in Patients with Cerebral and Systemic Amyloid," Neuroscience Lett. 135:235-238 (1992).
Pasternack, J. M., et al., "Astrocytes in Alzheimer's Disease Gray Matter Express .alpha.,.sub.1 -Antichymotrypsin mRNA," Am. J. Path., 135:827-827-834 (1989).
Koo, E. H., et al., "Developmental Expression of .alpha..sub.1 -Antichymotrypsin in Brain May be Related to Astrogliosis," Neurobiol. Aging, 12:495-501 (1991).
Rebeck, G. W., et al., "Apolipoprotein E in Sporadic Alzheimer's Disease: Allelic Variation and Receptor Interactions," Neuron, 11::575-580 (1983).
Strittmatter, W. J., et al., "Apolipoprotein E: High-Avidity Binding to .beta.-Amyloid and Increased Frequency of Type 4 Allele in Late-Onset Familial Alzheimer's Disease," Proc. Natl. Acad. Sci., USA, 90:1977-1981 (Mar. 1993).
Corder, E. H., et al., "Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families," Science, 261:921-923 (Aug. 13, 1993).
Sanan, D. A., et al., "Apoliprotein E Associates with .beta. Amyloid Peptide of Alzheimer's Disease to Form Novel Monofibrils
Huff Sheela J.
President and Fellows of Harvard College
Scheiner Toni R.
LandOfFree
Compounds and methods for inhibiting .beta.-protein filament for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for inhibiting .beta.-protein filament for, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for inhibiting .beta.-protein filament for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1882758